Drug
Calcitonin
Calcitonin is a pharmaceutical drug with 8 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Total Trials
8
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 5 completed trials
Completion Rate
100%(5/5)
Active Trials
3(38%)
Results Posted
40%(2 trials)
Phase Distribution
Ph phase_3
1
13%
Ph phase_4
2
25%
Ph not_applicable
4
50%
Ph phase_2
1
13%
Phase Distribution
0
Early Stage
1
Mid Stage
3
Late Stage
Phase Distribution8 total trials
Phase 2Efficacy & side effects
1(12.5%)
Phase 3Large-scale testing
1(12.5%)
Phase 4Post-market surveillance
2(25.0%)
N/ANon-phased studies
4(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
5 of 5 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
8
all time
Status Distribution
Active(3)
Completed(5)
Detailed Status
Completed5
Recruiting3
Development Timeline
Analytics
Development Status
Total Trials
8
Active
3
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (12.5%)
Phase 31 (12.5%)
Phase 42 (25.0%)
N/A4 (50.0%)
Trials by Status
completed563%
recruiting338%
Recent Activity
3 active trials
Showing 5 of 8
recruitingphase_3
Subcutaneous Calcitonin in Acute Herpes Zoster
NCT07655804
recruitingnot_applicable
Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
NCT05805683
recruitingphase_4
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
NCT03935984
completedphase_4
Hypothyroidism Treated With Calcitonin
NCT03342001
completednot_applicable
Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
NCT00478335
Clinical Trials (8)
Showing 8 of 8 trials
NCT07655804Phase 3
Subcutaneous Calcitonin in Acute Herpes Zoster
NCT05805683Not Applicable
Calcitonin Therapy on Incidence and Severity of Neuropathic Pain After Spinal Cord Injury
NCT03935984Phase 4
Calcitonin Pre-treatment to Improve SPECT-CT Sensitivity
NCT03342001Phase 4
Hypothyroidism Treated With Calcitonin
NCT00478335Not Applicable
Pharmacologic Treatment of Congenital Nephrogenic Diabetes Insipidus
NCT02115360Not Applicable
Epidural Calcitonin in Lower Limb Amputation
NCT00688077Not Applicable
FGF-23 Suppressibility by Calcitonin
NCT00004358Phase 2
Phase II Study of Calcitonin for Tumoral Calcinosis
All 8 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 8